SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Arbutus Biopharma Corporation backtest

10 trend-following strategies were compared on the full daily history of Arbutus Biopharma Corporation. 10 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 6.4%, MDD -74.6%).

Data 2007-07-26 ~ 2026-07-31daily bars 4,784 (19.0 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -2.0%, drawdown -97.2%).

Sharpe leader (same as main): Supertrend — CAGR 14.3%, MDD -80.1%, Sharpe 0.49, 45% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 16.3%p higher than buy and hold, while drawdown improves by 17.1%p (CAGR 6.4%, MDD -74.6%, exposure 41%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=15, mult=4.3
14.3%-80.1%0.490.1812.8x6245%
볼린저 밴드 돌파
n=17, k=1.2
11.7%-75.4%0.440.158.2x28633%
EMA 크로스오버
fast=12, slow=33
10.7%-85.7%0.430.136.9x13246%
MACD
fast=20, slow=25, signal=11
9.5%-85.3%0.430.115.6x27851%
SMA 크로스오버
fast=25, slow=66
10.4%-75.1%0.430.146.5x7147%
Donchian 채널 돌파
entryN=59, exitN=49
8.5%-86.9%0.400.104.8x3743%
Parabolic SAR
step=0.045, maxStep=0.14
7.0%-84.2%0.390.083.6x52646%
ROC 모멘텀
n=57, threshold=0.07
7.9%-76.7%0.380.104.2x23039%
Keltner 채널 돌파
emaPeriod=30, atrPeriod=26, mult=2.1
8.8%-83.3%0.380.115.0x10223%
ADX / DI 방향성
period=13, threshold=16
6.4%-74.6%0.370.093.2x32041%
Buy and hold-2.0%-97.2%0.37-0.020.7x1100%
1x 10x 2008 2011 2014 2017 2020 2023 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -24% -49% -73% -97% 2008 2011 2014 2017 2020 2023 2026 Buy and holdSupertrend
Supertrend maximum drawdown -80.1% (2009-05-12 → 2012-07-17), recovered after 1,738 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next